aripiprazole has been researched along with Nerve Pain in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aghamiri, H; Dehpour, AR; Hassanzadeh, F; Khalilzadeh, M; Shafaroodi, H | 1 |
| Furgała, A; Sałat, K; Sałat, R | 1 |
2 other study(ies) available for aripiprazole and Nerve Pain
| Article | Year |
|---|---|
Aripiprazole prevents from development of vincristine-induced neuropathic nociception by limiting neural NOS overexpression and NF-kB hyperactivation.
Topics: Animals; Antineoplastic Agents, Phytogenic; Aripiprazole; Dopamine Agonists; Gene Expression Regulation; Male; Neuralgia; NF-kappa B; Nitric Oxide Synthase Type I; Nociception; Rats; Rats, Wistar; Vincristine | 2020 |
Interventional and preventive effects of aripiprazole and ceftriaxone used alone or in combination on oxaliplatin-induced tactile and cold allodynia in mice.
Topics: Animals; Aripiprazole; Ceftriaxone; Drug Therapy, Combination; Hyperalgesia; Male; Mice; Neuralgia; Oxaliplatin; Pain Measurement; Pain Threshold | 2019 |